Skip to main content
. 2015 May 13;13:157. doi: 10.1186/s12967-015-0513-1

Table 2.

Positive and negative controls

Assay NaCl (negative control)a SEB (1. positive control)a CEFT (2. positive control)a
IFNγ [pg/ml] IL2 [pg/ml] IFNγ [pg/ml] IL2 [pg/ml] IFNγ [pg/ml] IL2 [pg/ml] N
Group
HCb 8 ± 2 2 ± 1 66,537 ± 8485 22,762 ± 1399 1681 ± 361 125 ± 36 80
AHBb 15 ± 5 3 ± 1 45,083 ± 14,487 10,737 ± 2148 458 ± 278 22 ± 11 8
CHBb, NUC treatment naive 41 ± 22 1 ± 1 65,734 ± 8837 18,439 ± 1244 1490 ± 669 220 ± 173 40
CHBb, NUC treated 17 ± 6 2 ± 1 107,200 ± 30,799 20,838 ± 1357 3186 ± 1383 318 ± 293 32

aThe data are shown as means ± standard error of mean (S.E.M.). SEB and CEFT values are given after deduction of background values (NaCl, negative control)

bHC = healthy controls, AHB = acute hepatitis B, CHB = chronic hepatitis B